drugset / Trial / NCT03839875

Evaluation of Efficacy and Safety of Gynomax® XL Ovule

NCT03839875

Phase 4 Completed 116 enrolled Exeltis Turkey MonitorCRO · collab
NaSingle-groupOpen-labelTreatment

Summary

Efficacy and safety of Gynomax® XL ovule in the treatment of trichomonal vaginitis, bacterial vaginosis, candidal vulvovaginitis and mixed vaginal infections will be evaluated in this open label, single-arm, multicentral study.

Timeline

Start
2019-04-03
Primary completion
2019-08-09
Completion
2019-08-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified
Subject tinidazole Small molecule
Subject tioconazole Small molecule